About the Study Therapy

What is the study therapy?

The study therapy is called ONCOFID-P-B. ONCOFID-P-B is made by combining paclitaxel (a common anticancer medicine) with hyaluronic acid. Hyaluronic acid may be able to help the anticancer medicine to be more effective. ONCOFID-P-B is investigational, which means it is currently being studied. ONCOFID-P-B is given in the same way as BCG. It is delivered straight to the bladder through a catheter.

Will I receive the study therapy?

Yes. You will receive the study therapy (delivered through a catheter) once a week for 12 weeks during the induction phase and 12 more weeks during the possible re-induction phase. If you participate in the maintenance phase, you will receive study therapy monthly for an additional 12 months.

What is an “investigational medicine?”

Investigational means the study medication is not approved by regulatory authorities like the Medicines and Healthcare products Regulatory Agency (MHRA), US Food and Drug Administration (FDA) or European Medicines Agency (EMA), and it can only be used in clinical research studies like Orion-BC.